Presentation is up on the small-mid conference. Nothing too much to add from the last one but the MCI planning is complete and they will announce the parameters of the study fairly soon. Still a lot of excitement and mystery from the 4th trial they want to run and they claim the feasibility is "advanced". The only reason they haven't announced it would be because there is a 3rd party involved in the development/funding, hopefully.
Trial start date still ambiguous.
emphasis on conservative figures yielding greater than $14 billion US per year for MCI alone.
Bill continues to insinuate an overlap between MCI and XanaHES.
could see .04, page-160
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
